Cargando…
Utilization of Targeted RNA-Seq for the Resolution of Variant Pathogenicity and Enhancement of Diagnostic Yield in Dysferlinopathy
For inherited diseases, obtaining a definitive diagnosis is critical for proper disease management, family planning, and participation in clinical trials. This can be challenging for dysferlinopathy due to the significant clinical overlap between the 30+ subtypes of limb–girdle muscular dystrophy (L...
Autores principales: | Rufibach, Laura, Berger, Kiera, Chakravorty, Samya, Emmons, Sarah, Long, Laurie, Gibson, Greg, Hegde, Madhuri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056012/ https://www.ncbi.nlm.nih.gov/pubmed/36983702 http://dx.doi.org/10.3390/jpm13030520 |
Ejemplares similares
-
Detection of Dysferlin Gene Pathogenic Variants in the Indian Population in Patients Predicted to have a Dysferlinopathy Using a Blood-based Monocyte Assay and Clinical Algorithm: A Model for Accurate and Cost-effective Diagnosis
por: Dastur, Rashna Sam, et al.
Publicado: (2017) -
The Clinical Outcome Study for dysferlinopathy: An international multicenter study
por: Harris, Elizabeth, et al.
Publicado: (2016) -
Clinical and Genomic Evaluation of 207 Genetic Myopathies in the Indian Subcontinent
por: Chakravorty, Samya, et al.
Publicado: (2020) -
Therapeutic exon skipping for dysferlinopathies?
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2010) -
Dysferlin and Animal Models for Dysferlinopathy
por: Kobayashi, Kinji, et al.
Publicado: (2012)